Navigation Links
A rare diagnosis in the operation room: Kidney atrophy due to duplicated colon in an adult
Date:2/22/2008

Gastrointestinal congenital anomalies are rare entities in an adult patient. Commonly they are located in the upper gastrointestinal system and present with intestinal symptoms such as bleeding, obstruction and/or perforation of the intestine. One extraordinary case of colon duplication was recently reported in the January 28 issue of the World Journal of Gastroenterology because of its great significance in presenting with hydronephrotic atrophy of the right kidney, rather than gastrointestinal symptoms, in an adult. This article will undoubtedly be of interest to health professionals.

The article describes a male patient who presented to Dr. Sahin Kabay and Dr. Faik YAYLAK of Dumlupinar University Hospital, Turkey, in 2006. This patient was quite a challenge for Dr. Kabay and Dr. Yaylak. He was a 28-year-old man with a palpable mass in the right flank. He was undiagnosed for his intermittent complaints of right flank pain for several months.

The initial efforts were to treat and to control his urinary tract infection. At primary diagnostic imaging studies, Dr. Kabay and Dr. Yaylak noted the mass in the right flank with hydronephrosis of the right kidney. Their further efforts to clarify the origin of the mass with intravenous pyelography, scintigraphy and even colonoscopy were not enough to make a diagnosis pre-operatively. Computed tomography images demonstrated the continuum of the mass with the right colon. Dr. Kabay and his surgical team scheduled their patient for a laparotomy under general anesthesia. During the operation, the surgical team was excited to diagnose the double tubular colon as the cause of the pathological mass. The mass with duplicated colon and appendix was removed uneventfully. The postsurgical course of the patient was not significant and he recovered well over the following year.

In an effort to make a correct diagnosis in the patient, Dr. Kabay and Dr. Yaylak were forced to carry out a fine pre-operative
'/>"/>

Contact: Jing Zhu
wjg@wjgnet.com
0086-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Optimal band imaging with endoscopy facilitates the diagnosis of depressed-type early gastric cancer
2. Timely Cancer Diagnosis Linked to Insurance Status
3. Putting the Medical Profession on Notice!: Widow Tells Tragic Story of How Her Husband Died Due to Misdiagnosis and Mistreatment
4. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
5. Breast cancer diagnosis comes late for women in gentrifying neighborhoods
6. Improved diagnosis of cutaneous leishmaniasis thanks to new techniques
7. Study raises questions about diagnosis, medical treatment of ADHD
8. Time Critical Diagnosis Task Force Convenes in Jefferson City
9. Dementia Diagnosis Typically Means Death Within Five Years
10. New research demonstrates potential diagnosis, treatment benefits
11. Treating oft ignored non-cancer health issues after cancer diagnosis prolongs survival
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4H1N1 Focus of California Hospital Association Disaster Planning Conference 57101 1H1N1 Focus of California Hospital Association Disaster Planning Conference 57101 2H1N1 Focus of California Hospital Association Disaster Planning Conference 57101 3Intelligent Design Film to Premiere at Sam Noble Oklahoma Museum of Natural History Sept 29 14029 1Intelligent Design Film to Premiere at Sam Noble Oklahoma Museum of Natural History Sept 29 14029 2PolyOne Presented with Frost 26 Sullivan Medical Product Award 57096 1PolyOne Presented with Frost 26 Sullivan Medical Product Award 57096 2